
دکیمی
کیمیدارو
تریدر | نوع سیگنال | حد سود/ضرر | زمان انتشار | مشاهده پیام |
---|---|---|---|---|
![]() famatakeRank: 227 نیاز به اشتراک | خرید | حد سود: تعیین نشده حد ضرر: تعیین نشده نیاز به اشتراک | 4/29/2025 | نیاز به اشتراک |
![]() بانک ملی ایرانRank: 377 نیاز به اشتراک | خرید | حد سود: تعیین نشده حد ضرر: تعیین نشده نیاز به اشتراک | 11/16/2020 | نیاز به اشتراک |
![]() سیگنال پلاسRank: 1200 نیاز به اشتراک | خرید | حد سود: تعیین نشده حد ضرر: تعیین نشده نیاز به اشتراک | 4/26/2025 | نیاز به اشتراک |
![]() 𝐒𝒊𝒈𝒏𝒂𝒍 𝐒𝒂𝒃𝒛| سیگنال سبزRank: 3258 | خرید | حد سود: تعیین نشده حد ضرر: تعیین نشده | 8/17/2025 | |
![]() 📈📊بورس(جام)📈📊Rank: 3314 | خرید | حد سود: تعیین نشده حد ضرر: تعیین نشده | 8/3/2025 |
Adjusted Price Chart of دکیمی and دکیمی Signal Trend
سود 3 Months :
Who made the most profit from دکیمی?

نوسان گیری مدرن

𝐒𝒊𝒈𝒏𝒂𝒍 𝐒𝒂𝒃𝒛| سیگنال سبز

boursvafarabours

دکتر سید پرویز جلیلی: دانشگاه بورس
hamid2030
سیگنالهای دکیمی
Filter
Signal Type
Trader Type
Time Frame
نوع پیام

نرم افزار تحلیل گر بورس - دایموند
#Group sales report #medicine In August 1404, pharmaceutical companies sold 18259 billion tomans, which increased by 50 % compared to the same year last year. 💵 Export sales of 332 billion tomans, which increased by 76 percent from the same year. #Dezagress Company registered the highest export with 116 billion USD. ✅ #Broadcasting Company with 3602 billion USD had the highest sales in the company. The following companies recorded the highest growth rate compared to the same year. #1124% K_B_S #204% #145%Dabor #129% medicine #123%late #116% Daller #107% Dekimi #Caspian 105%🔥 #Degree 103% #93%Valley #91% Long #Debacco 88%🔥 #Dafra 76% #76% detection #71%🔥 #68% Broadcast #58% Dezagress #Damidid 58% #57% decay #56% dendina #50% decline #49% Defense #47% Decoration #Depars 45%🔥 #Dana 33%🔥 #Deller 33% #32% Dasouh #30% Dehravi #18% Hijra #3% dock #2% Deanko #Dajaber 1% #Dhavi 🔥 (First Year of Report) #Dashiri (first year of report) 📅 Last Update: 1404/16/13 Support your shares by submitting this report in groups @dndir

بورسی های گیلان
#Medication (2) monthly ❇️ 5 months performance to 5 months 403 (Billion USD) ●#Dajabar income [602 MT] 6% drop ●#Biotics Income [742 MT] Growth 23% Growth ● #Darm Revenue [432 MT] Growth 40% ●#Income Revenue [503 MT] Growth 32% ●#Dekimi Income [394 MT] Growth 48% Growth ●#KBC Revenue [268m] Growth 307% ●#Long revenue [4,980mm] 2% drop ●#Claimer Income [826 MT] Growth 121% ●#Disaster Revenue [963 MT] Growth 42% Growth ●#Dabor Revenue [1,410 MT] Growth 55% ●#Daine of Income [158m] Growth 41% ●#24% Growth Income [484 MT] ●#53% growth in revenue [583 MT] ●#Lolk Income [941m] Growth 67% ●#Deanco Income [249 MT] Growth 9% Growth ●#Delibal Revenue [449 MT] Growth 84% Growth ●#Dasouh Revenue [341m] 12% Growth ●#Druz income [182m] 15% drop ●#Income Income [333m] Growth 71% ●#Di in Revenue [293 MT] Growth 35% Growth

مانا بورس
Pharmaceutical companies' sales rise in August Out of the total sales reports of 4 pharmaceutical companies in August, the following companies have shown the best sales growth compared to previous periods: #KBC #Dabur #Dadam #Medicine #Dalber #Valley #Dukimi #Dischool #Dallek #Caspian #Medication 📱 @fardaname

بورس طارم
#Declaration #Dejaber #Dezravi #Biotics #Decorations #Daddy #Kib_S #Diran #Desthi #Drug #Drug #Dahavi #Hijra #Deli #Caspian #Dekimi #Dadam #Dadam #Dalbari #Dasta #Deller #Deller # #Domain #Deco -Dafara #Defara #Dehz #Dafra #Defara #Department #Dabid #Dasouh #Deanko #Richmak #Dabur اری Important financial ratios in the drug and pharmaceutical product group (Spring 1404) - Latest Financial Statement Published The Best Profit Margin Ratio: Caspian, Decoration, Dafra, Dezina, Design The best ratio of profit margins: Defra, Deafra, Dashiri, Dezagress, Caspian The lowest ratio of P/E TTM: Dajaber, Dashiri, Player, Dezagress The least debt ratio: Defra, Dahad, Dahawi Most of the Returns' Returns: Dashiri, Dabur, Caspian Increasing the profit margin compared to the previous season: Devil, Detection, Dezravi, Biotics, Decorations, Drugs, Longness, Longness, Dadam, Dazguz, Dana, Dana, Damin, Dafara, Dalc, Dasoum, Dasouh, Dabor

بورس طارم
#Declaration #Dejaber #Dezravi #Biotics #Decorations #Daddy #Kib_S #Diran #Desthi #Drug #Drug #Dahavi #Hijra #Deli #Caspian #Dekimi #Dadam #Dadam #Dalbari #Dasta #Deller #Deller # #Domain #Deco -Dafara #Defara #Dehz #Dafra #Defara #Department #Dabid #Dasouh #Deanko #Richmak #Dabur اری Important financial ratios in the drug and pharmaceutical product group (Spring 1404) - Latest Financial Statement Published The Best Profit Margin Ratio: Caspian, Decoration, Dafra, Dezina, Design The best ratio of profit margins: Defra, Deafra, Dashiri, Dezagress, Caspian The lowest ratio of P/E TTM: Dajaber, Dashiri, Player, Dezagress The least debt ratio: Defra, Dahad, Dahawi Most of the Returns' Returns: Dashiri, Dabur, Caspian Increasing the profit margin compared to the previous season: Devil, Detection, Dezravi, Biotics, Decorations, Drugs, Longness, Longness, Dadam, Dazguz, Dana, Dana, Damin, Dafara, Dalc, Dasoum, Dasouh, Dabor
#Dukimi #Report_Connaire #Courses_1_140/05/31 #Industrial_Cimidaro Company ▪️ Kimidaru Industrial Company has sold its products during the 1 -month performance leading to 1/05/31, equivalent to 1,071,905 million rials. ▪️ Dukimi, with a recorded capital of 576,000 million Rials, had a 5,933,557 million rials in the 8 -month performance of the fiscal year ending 140/09/30. 1404-06-05 18:58:21 (1398603) ایرین ایرین @codal360_ir

صندوق سرمایه گذاری قابل معامله بخشی کیان
The Kian Trading Investment Fund has sold 0.089 million Dukim shares on 14/06/06 and currently holds 1.081 % of Deachi's shares in its equity portfolio.

🏆بورس تکنیک 📉💰
🟢 Symbols with #most_case_ 🟡 After the retailer is gathered 🕘 Today Tuesday, August 6, 2008 #Kasra #Khamhhor #Dahavi #Kimatak #Ovan #Valsnem #Nian #Sepidar #Bakhar #Shamli #Ghaddasht #Vespa #Homeland #Dukim #Zangina

𝐒𝒊𝒈𝒏𝒂𝒍 𝐒𝒂𝒃𝒛| سیگنال سبز
#Dukimi from the sales queue to the shopping queue

𝐒𝒊𝒈𝒏𝒂𝒍 𝐒𝒂𝒃𝒛| سیگنال سبز
#Dekimi of sales queue we buy oscillating
Disclaimer
Any content and materials included in Sahmeto's website and official communication channels are a compilation of personal opinions and analyses and are not binding. They do not constitute any recommendation for buying, selling, entering or exiting the stock market and cryptocurrency market. Also, all news and analyses included in the website and channels are merely republished information from official and unofficial domestic and foreign sources, and it is obvious that users of the said content are responsible for following up and ensuring the authenticity and accuracy of the materials. Therefore, while disclaiming responsibility, it is declared that the responsibility for any decision-making, action, and potential profit and loss in the capital market and cryptocurrency market lies with the trader.